London, UK -- (SBWIRE) -- 05/21/2018 -- Global Pain Management Drugs and Devices Market is accounted for $. billion in 2016 and is expected to reach $. billion by 2023 growing at a CAGR of .% during the forecast period. Growing healthcare industry across the globe, rapid technological developments and increasing various pain disorders tied with rising global geriatric people are some of the key factors propelling the market growth. However, factors such as availability of alternative therapies, drug abuse and patent expiration of prescription drugs are hindering the market.

Looking for more information on this market? Request for Free Sample Copy of Report @ http://www.researchformarkets.com/sample/pain-management-drugs-and-devices-global-market-44802

Neuromodulation is technology that is used for the alteration or modulation of the nerve activity by using chemical agents or electrical stimulation to the specific neurological sites in the body. Most of the neuromodulation devices work through electrical stimulation. Neuromodulation devices are used by the application of electrodes to the brain, peripheral nerves or the spinal cord. The electrode leads in neuromodulation devices are connected through an extension cable to a power source and pulse generator, which generates required electrical impulses. North America is anticipated to hold the largest market share due to the rising incidence of chronic diseases, increasing government support, growing middle-class population and disposable income levels in this region.

Some of the key players in the Pain Management Drugs and Devices Market include Abbott Laboratories, Endo International, Abbvie, DJO Global Inc., Johnson & Johnson, Novartis International AG, Grunenthal Gmbh, ELI Lilly & Co, Hisamitsu Pharmaceutical Co. Inc., Pfizer Inc., Astrazeneca Plc, Purdue Pharma LP, Glaxosmithkline, Medtronic and Boston Scientific Corp.

Device Types Covered:

- Neuromodulation Devices
- Analgesic Infusion Pumps
- Ablation Devices
- Electrical stimulation devices

Drug Classes Covered:

- Non-Narcotic Analgesics
- Narcotic Pain Management
- Opioids
- Antidepressent
- Anesthetics
- NSAIDS
- Anticovulsants
- Anti-Migraine Agents
- Other Drug Classes

Applications Covered:

- General Pain
- Dental Pain
- HIV/AIDS Pain
- Migraine Pain
- Orthopedic/Musculoskeletal Pain
- Neuropathic Pain
- Cancer Pain
- Fibromyalgia Pain
- Surgical Pain
- Other Applications

Indications Covered:

- Arthritic Pain
- Chronic back pain

Mode of Purchases Covered:

- Over-the-counter Devices
- Over-the-counter Devices

What our report offers:

- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Get Instant Discount on This Report @ http://www.researchformarkets.com/discount/pain-management-drugs-and-devices-global-market-44802

Short review On Table Of Content-

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Pain Management Drugs and Devices Market, By Device Type
5.1 Introduction
5.2 Neuromodulation Devices
5.2.1 Spinal Cord Stimulation (SCS) Devices
5.2.2 Sacral Nerve Stimulation Devices
5.2.3 Vagus Nerve Stimulation Devices
5.2.4 Deep Brain Stimulation Devices
5.3 Analgesic Infusion Pumps
5.3.1 Intrathecal Infusion Pumps
5.3.2 External Infusion Pumps
5.4 Ablation Devices
5.4.1 Radiofrequency Ablation Devices
5.4.2 Cryoablation Devices
5.5 Electrical stimulation devices
5.5.1 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
5.5.2 Neuromuscular Electrical Stimulation (NMES/EMS) Devices
5.5.3 Other Electrical Stimulation Devices

6 Global Pain Management Drugs and Devices Market, By Drug Classes
6.1 Introduction
6.2 Non-Narcotic Analgesics
6.3 Narcotic Pain Management
6.4 Opioids
6.5 Antidepressent
6.6 Anesthetics
6.7 NSAIDS
6.8 Anticovulsants
6.9 Anti-Migraine Agents
6.10 Other Drug Classes

7 Global Pain Management Drugs and Devices Market, By Application
7.1 Introduction
7.2 General Pain
7.3 Dental Pain
7.4 HIV/AIDS Pain
7.5 Migraine Pain
7.6 Orthopedic/Musculoskeletal Pain
7.7 Neuropathic Pain
7.8 Cancer Pain
7.9 Fibromyalgia Pain
7.10 Surgical Pain
7.11 Other Applications

8 Global Pain Management Drugs and Devices Market, By Indication
8.1 Introduction
8.2 Arthritic Pain
8.3 Chronic back pain

9 Global Pain Management Drugs and Devices Market, By Mode of Purchase
9.1 Introduction
9.2 Over-the-counter Devices
9.3 Prescription-based Devices

10 Global Pain Management Drugs and Devices Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Abbott Laboratories
12.2 Endo International
12.3 Abbvie
12.4 DJO Global Inc.
12.5 Johnson & Johnson
12.6 Novartis International AG
12.7 Grunenthal Gmbh
12.8 ELI Lilly & Co.
12.9 Hisamitsu Pharmaceutical Co. Inc.
12.10 Pfizer Inc.
12.11 Astrazeneca Plc
12.12 Purdue Pharma LP
12.13 Glaxosmithkline
12.14 Medtronic
12.15 Boston Scientific Corp

If you have any special requirements, please let us know and we will offer you the report as you want.

Know More About our Knowledge store @ http://www.researchformarkets.com/reports/pain-management-drugs-and-devices-global-market-44802